Recent progress in targeted membrane protein degradation technology based on aptamers for disease treatment
Biomaterials Science · 2026
DOI: 10.1039/d5bm01333j ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials Science, 2026. Verfasst von Xiaolong Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of Technology, Chongqing 400054, China. fyqiao@cqut.…. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Membrane Proteins, Neoplasms. Die Arbeit nennt 109 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Science and Technology Commission.
Abstract (Originalsprache)
Conventional targeted protein degradation (TPD) is often ineffective against many disease-related proteins. This review summarizes recent advances in aptamer-based TPD for the degradation of “undruggable” targets, expanding therapeutic possibilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of Technology, Chongqing 400054, China. fyqiao@cqut.edu.cn.
Förderung
- National Natural Science Foundation of China
- Chongqing Science and Technology Commission
Zitieren
APA
Li, X., Wang, Y., He, T., Tian, J., Qiao, F., & Li, D. (2026). Recent progress in targeted membrane protein degradation technology based on aptamers for disease treatment. Biomaterials Science. https://doi.org/10.1039/d5bm01333j
Vancouver
Li X, Wang Y, He T, Tian J, Qiao F, Li D. Recent progress in targeted membrane protein degradation technology based on aptamers for disease treatment. Biomaterials Science. 2026. doi:10.1039/d5bm01333j
BibTeX
@article{Li2026,
author = {Li, Xiaolong and Wang, Yanni and He, Tingting and Tian, Jian and Qiao, Fangyu and Li, Daxiu},
title = {Recent progress in targeted membrane protein degradation technology based on aptamers for disease treatment},
journal = {Biomaterials Science},
year = {2026},
doi = {10.1039/d5bm01333j}
}
EUVIMED